how will rdca-dap® support patient-focused drug development?
Published 2 years ago • 179 plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
58:09
patient focused drug development - how rdca-dap can help
-
4:17
rdca-dap: shortening the timeline for developing new treatments for rare diseases
-
3:37
what is patient-focused drug development (pfdd)?
-
57:50
drug development for rare diseases: a community conversation
-
3:44
rare disease challenges in each step of the drug development process
-
5:39
plan do study act (pdsa)
-
5:18
10 tips for newly diagnosed rare disease patients and families
-
2:36
10 tips for new rare disease advocates from current ones
-
31:11
from data to cures: speeding the way for rare diseases
-
4:33
the drug development process
-
1:50
rare disease drug development education series trailer
-
58:44
shortening the timeline for developing new treatments - how the rdca-dap can help
-
59:44
advocating for a rare disease advisory council in your state
-
55:49
sharing data with rdca-dap: your questions answered
-
2:05
how can patients and advocates help accelerate drug development?
-
56:43
how patient nonprofits can help accelerate drug development
-
3:23
education; making a rare impact
-
2:11
research; making a rare impact
-
4:18:45
post-transplant lymphoproliferative disease externally-led patient-focused drug development meeting
-
7:52
nord , part 1 of 3, health care reform and the rare disease community.
-
59:23
what does patient focused drug development look like for rare diseases sd 480p